304 related articles for article (PubMed ID: 18258799)
1. Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-alpha production.
Meyer-Wentrup F; Benitez-Ribas D; Tacken PJ; Punt CJ; Figdor CG; de Vries IJ; Adema GJ
Blood; 2008 Apr; 111(8):4245-53. PubMed ID: 18258799
[TBL] [Abstract][Full Text] [Related]
2. BDCA-2 signaling inhibits TLR-9-agonist-induced plasmacytoid dendritic cell activation and antigen presentation.
Jähn PS; Zänker KS; Schmitz J; Dzionek A
Cell Immunol; 2010; 265(1):15-22. PubMed ID: 20673884
[TBL] [Abstract][Full Text] [Related]
3. HCV glycoprotein E2 is a novel BDCA-2 ligand and acts as an inhibitor of IFN production by plasmacytoid dendritic cells.
Florentin J; Aouar B; Dental C; Thumann C; Firaguay G; Gondois-Rey F; Soumelis V; Baumert TF; Nunès JA; Olive D; Hirsch I; Stranska R
Blood; 2012 Nov; 120(23):4544-51. PubMed ID: 23053572
[TBL] [Abstract][Full Text] [Related]
4. DCIR is endocytosed into human dendritic cells and inhibits TLR8-mediated cytokine production.
Meyer-Wentrup F; Cambi A; Joosten B; Looman MW; de Vries IJ; Figdor CG; Adema GJ
J Leukoc Biol; 2009 Mar; 85(3):518-25. PubMed ID: 19028959
[TBL] [Abstract][Full Text] [Related]
5. Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR.
Klechevsky E; Flamar AL; Cao Y; Blanck JP; Liu M; O'Bar A; Agouna-Deciat O; Klucar P; Thompson-Snipes L; Zurawski S; Reiter Y; Palucka AK; Zurawski G; Banchereau J
Blood; 2010 Sep; 116(10):1685-97. PubMed ID: 20530286
[TBL] [Abstract][Full Text] [Related]
6. DCIR interacts with ligands from both endogenous and pathogenic origin.
Bloem K; Vuist IM; van den Berk M; Klaver EJ; van Die I; Knippels LM; Garssen J; García-Vallejo JJ; van Vliet SJ; van Kooyk Y
Immunol Lett; 2014; 158(1-2):33-41. PubMed ID: 24239607
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cell immunoreceptors: C-type lectin receptors for pattern-recognition and signaling on antigen-presenting cells.
Kanazawa N
J Dermatol Sci; 2007 Feb; 45(2):77-86. PubMed ID: 17046204
[TBL] [Abstract][Full Text] [Related]
8. Human BDCA2+CD123+CD56+ dendritic cells (DCs) related to blastic plasmacytoid dendritic cell neoplasm represent a unique myeloid DC subset.
Yu H; Zhang P; Yin X; Yin Z; Shi Q; Cui Y; Liu G; Wang S; Piccaluga PP; Jiang T; Zhang L
Protein Cell; 2015 Apr; 6(4):297-306. PubMed ID: 25779340
[TBL] [Abstract][Full Text] [Related]
9. Signaling and immune regulatory role of the dendritic cell immunoreceptor (DCIR) family lectins: DCIR, DCAR, dectin-2 and BDCA-2.
Kanazawa N; Tashiro K; Miyachi Y
Immunobiology; 2004; 209(1-2):179-90. PubMed ID: 15481152
[TBL] [Abstract][Full Text] [Related]
10. TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients.
Wu P; Wu J; Liu S; Han X; Lu J; Shi Y; Wang J; Lu L; Cao X
Clin Immunol; 2008 Oct; 129(1):40-8. PubMed ID: 18684674
[TBL] [Abstract][Full Text] [Related]
11. DCIR negatively regulates CpG-ODN-induced IL-1β and IL-6 production.
Zhao X; Shen Y; Hu W; Chen J; Wu T; Sun X; Yu J; Wu T; Chen W
Mol Immunol; 2015 Dec; 68(2 Pt C):641-7. PubMed ID: 26514427
[TBL] [Abstract][Full Text] [Related]
12. C-type lectin receptors MR and DC-SIGN are involved in recognition of hemocyanins, shaping their immunostimulatory effects on human dendritic cells.
Villar J; Salazar ML; Jiménez JM; Campo MD; Manubens A; Gleisner MA; Ávalos I; Salazar-Onfray F; Salazar F; Mitchell DA; Alshahrani MY; Martínez-Pomares L; Becker MI
Eur J Immunol; 2021 Jul; 51(7):1715-1731. PubMed ID: 33891704
[TBL] [Abstract][Full Text] [Related]
13. Plasmacytoid dendritic cell number and responses to Toll-like receptor 7 and 9 agonists vary in HIV Type 1-infected individuals in relation to clinical state.
Kaushik S; Teque F; Patel M; Fujimura SH; Schmidt B; Levy JA
AIDS Res Hum Retroviruses; 2013 Mar; 29(3):501-10. PubMed ID: 23131038
[TBL] [Abstract][Full Text] [Related]
14. APCs express DCIR, a novel C-type lectin surface receptor containing an immunoreceptor tyrosine-based inhibitory motif.
Bates EE; Fournier N; Garcia E; Valladeau J; Durand I; Pin JJ; Zurawski SM; Patel S; Abrams JS; Lebecque S; Garrone P; Saeland S
J Immunol; 1999 Aug; 163(4):1973-83. PubMed ID: 10438934
[TBL] [Abstract][Full Text] [Related]
15. The Consequences of Multiple Simultaneous C-Type Lectin-Ligand Interactions: DCIR Alters the Endo-Lysosomal Routing of DC-SIGN.
García-Vallejo JJ; Bloem K; Knippels LM; Garssen J; van Vliet SJ; van Kooyk Y
Front Immunol; 2015; 6():87. PubMed ID: 25806031
[TBL] [Abstract][Full Text] [Related]
16. Activation of human plasmacytoid dendritic cells by TLR9 impairs Fc gammaRII-mediated uptake of immune complexes and presentation by MHC class II.
Benitez-Ribas D; Tacken P; Punt CJ; de Vries IJ; Figdor CG
J Immunol; 2008 Oct; 181(8):5219-24. PubMed ID: 18832675
[TBL] [Abstract][Full Text] [Related]
17. A type I interferon regulatory network for human plasmacytoid dendritic cells based on heparin, membrane-bound and soluble BDCA-2.
Venegas-Solis F; Staliunaite L; Rudolph E; Münch CC; Yu P; Freibert SA; Maeda T; Zimmer CL; Möbs C; Keller C; Kaufmann A; Bauer S
Proc Natl Acad Sci U S A; 2024 Mar; 121(12):e2312404121. PubMed ID: 38478694
[TBL] [Abstract][Full Text] [Related]
18. Efficient generation of a monoclonal antibody against the human C-type lectin receptor DCIR by targeting murine dendritic cells.
Heidkamp GF; Neubert K; Haertel E; Nimmerjahn F; Nussenzweig MC; Dudziak D
Immunol Lett; 2010 Aug; 132(1-2):69-78. PubMed ID: 20566350
[TBL] [Abstract][Full Text] [Related]
19. Zika Virus Inhibits IFN-α Response by Human Plasmacytoid Dendritic Cells and Induces NS1-Dependent Triggering of CD303 (BDCA-2) Signaling.
Bos S; Poirier-Beaudouin B; Seffer V; Manich M; Mardi C; Desprès P; Gadea G; Gougeon ML
Front Immunol; 2020; 11():582061. PubMed ID: 33193389
[TBL] [Abstract][Full Text] [Related]
20. The MEK1/2-ERK Pathway Inhibits Type I IFN Production in Plasmacytoid Dendritic Cells.
Janovec V; Aouar B; Font-Haro A; Hofman T; Trejbalova K; Weber J; Chaperot L; Plumas J; Olive D; Dubreuil P; Nunès JA; Stranska R; Hirsch I
Front Immunol; 2018; 9():364. PubMed ID: 29535732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
